Previous Close | 5.3260 |
Open | 4.6800 |
Bid | 4.8170 x N/A |
Ask | 4.8940 x N/A |
Day's Range | 4.6800 - 4.6800 |
52 Week Range | 4.6800 - 10.6800 |
Volume | |
Avg. Volume | 56 |
Market Cap | 384.858M |
Beta (5Y Monthly) | 2.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Editas Medicine ( NASDAQ:EDIT ) First Quarter 2024 Results Key Financial Results Revenue: US$1.14m (down 89% from 1Q...
Q1 2024 Editas Medicine Inc Earnings Call
Editas (EDIT) delivered earnings and revenue surprises of -20.63% and 90.26%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?